Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2008

Conditions

Healthy

Interventions

DRUG

ABT-143

Once, please see Arm Description for more details.

DRUG

ABT-335

Once, see Arm Description for more detail

DRUG

rosuvastatin

once, see Arm Description for more detail

Trial Locations (1)

Site Reference ID/Investigator# 13441, Orlando